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The systemic challenges of the COVID-19 pandemic require cross-
disciplinary collaboration in a global and timely fashion. Such 
collaboration needs open research practices and the sharing of 
research outputs, such as data and code, thereby facilitating research 
and research reproducibility and timely collaboration beyond borders. 
The Research Data Alliance COVID-19 Working Group recently 
published a set of recommendations and guidelines on data sharing 
and related best practices for COVID-19 research. These guidelines 
include recommendations for researchers, policymakers, funders, 
publishers and infrastructure providers from the perspective of 
different domains (Clinical Medicine, Omics, Epidemiology, Social 
Sciences, Community Participation, Indigenous Peoples, Research 
Software, Legal and Ethical Considerations). Several overarching 
themes have emerged from this document such as the need to 
balance the creation of data adherent to FAIR principles (findable, 
accessible, interoperable and reusable), with the need for quick data 
release; the use of trustworthy research data repositories; the use of 
well-annotated data with meaningful metadata; and practices of 
documenting methods and software. The resulting document marks 
an unprecedented cross-disciplinary, cross-sectoral, and cross-
jurisdictional effort authored by over 160 experts from around the 
globe. This letter summarises key points of the Recommendations and 
Guidelines, highlights the relevant findings, shines a spotlight on the 
process, and suggests how these developments can be leveraged by 
the wider scientific community.
Keywords 
Open science, Sharing research outputs in pandemics caused by 
infectious diseases, FAIR and CARE principles, Omics, Epidemiology, 
Social Science, Clinical Research, COVID-19
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Introduction
The coronavirus disease 2019 (COVID-19) pandemic is cur-
rently one of the most challenging global issues, with economic, 
social, political, cultural and scientific consequences (Nicola 
et al., 2020; Rajkumar, 2020). The rapid spread of the severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
virus and the need for global stewardship has led researchers to 
collaborate on a worldwide scale, escalating the production of 
scientific data and highlighting the urgency to provide those data 
in an accessible, re-usable, and timely manner.
To ensure the rapid sharing of high-quality data, the Research 
Data Alliance (RDA) established a rapid-response working 
group on COVID-19, which quickly grew to more than 600 
members, with over 160 individuals contributing actively to 
recommendations over a 10 week period. The working group was 
divided into four research areas (Clinical, Omics, Epidemiology, 
Social Sciences) with four cross-cutting themes (Community 
Participation, Indigenous Data, Legal and Ethical Considerations, 
Research Software).
The objective of this RDA working group, in the first instance, 
was to provide data sharing recommendations for research-
ers, clinicians, policymakers, funders, publishers, and provid-
ers of data sharing infrastructures concerning the most important 
challenges raised by the current pandemic.
The final version of the RDA COVID-19 Recommenda-
tions and Guidelines on Data Sharing (RDA COVID-19 WG, 
2020) was released on 30th June 2020 and provides up-to-
date advice across the eight areas mentioned above to support 
robust and meaningful data reuse for the COVID-19 pandemic 
management. Each sub-section of the 143-page document is 
organised into four main subparts: “Focus and Description”, 
“Scope”, “Policy recommendations” and “Guidelines”, allowing 
efficient navigation for the reader seeking precise information.
Prefaced by an executive summary, it provides essential refer-
ence text for relevant stakeholders, with granular guidelines for 
researchers and data managers preceded in each section by higher 
level recommendations to policymakers and funders. It is also 
connected to an extensive bibliography accessible via the par-
ticipative online service Zotero Library (RDA COVID-19 Zotero 
WG, 2020). An infographic was created to provide an over-
view and highlight key areas. Other resources, in particular a 
decision-making tool and a mindmap are in development so that 
readers can more efficiently navigate the document. These are 
being made available on the Value of RDA for COVID-19 web-
page. The comprehensive recommendations and related navi-
gation tools facilitate uptake by all stakeholders (including the 
public), who wish to access and contribute reliable information 
on the global COVID-19 research and response process.
Since disciplines and communities often develop ad hoc data 
management practices that are prone to becoming siloed, the 
report encourages data exchange between stakeholders. It high-
lights the advances and procedures in different disciplines, 
but crucially also draws attention to the commonalities between 
disciplines, fostering interdisciplinary action, understanding of 
the disciplines that stakeholders are not part of, and future 
collaboration. The RDA is in a unique position to develop such 
guidance due to its grassroots, participative tradition of interdisci-
plinary self-motivated dialogue and solutions-based outputs.
Recommendations
In this section, we provide a brief motivation for each sub-
group, the problems identified, and a summary of key 
recommendations, per group as well as overarching guidance.
Clinical guidelines
Healthcare measures and clinical research are at the forefront 
of combating the COVID-19 pandemic. Obtaining actionable 
clinical information about the disease and seeking an effective 
treatment to fight the infection are key to minimising the 
impact of this unprecedented global health challenge. Clinical 
trials should follow the International Council for Harmonisation 
(ICH) efficacy guidelines to ensure the data quality. As cases 
rise, the promotion of clinical data sharing is of utmost impor-
tance. Many studies and trials are performed under enormous 
time pressure, which can weaken the methodology and lead to 
preliminary results being published without a full review. We 
recommend making the data behind research available alongside 
research results. The recommendations detail how to use trust-
worthy repositories to provide transparency, integrity and context 
to data for timely discovery and the validation of new findings. 
A key goal is to avoid policy-making based on fraudulent 
studies, which in turn causes distrust in science (Group, The Editors 
of the Lancet, 2020). 
Omics guidelines
Omics-scale studies of SARS-CoV-2 are emerging rapidly 
with exceptional potential to unravel the mechanisms of the 
COVID-19 pathobiology. These studies offer new mechanistic 
insights into the pathogenesis of COVID-19 and ways forward 
for diagnostic and therapeutic intervention, while at the same 
time generating a tremendous amount of data. The Omics sub-
group was motivated to draft guidelines based on the requirement 
for rapid, open data sharing. This rapid sharing facilitates early 
insights into the molecular biology of the COVID-19 processes 
at a cellular level, possibly leading to new therapeutic targets, 
diagnostic markers and disease management. Omics research 
should be a collaborative effort to learn the genetic determinants 
of COVID-19 susceptibility, severity and outcomes. Thus, the 
use of domain-specific repositories to enable standardisation 
of terms and enforce metadata standards is mandated. Avail-
ability and re-usability of research data on COVID-19 in order 
to prevent unnecessary duplication of work is described for virus 
genomics, host genomics, proteomics, metabolomics, lipidomics, 
and structural data. The efforts of the RDA Omics working 
group provides clear recommendations of repositories to find 
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existing data depending on the target methodology in the above 
research areas, as well as best practices for sharing data and 
identifying the most prevalent data and metadata formats.
Epidemiology guidelines
An immediate understanding of the COVID-19 epidemiol-
ogy is crucial to slowing infections, minimising deaths, making 
informed decisions about when, and to what extent, to impose 
mitigation measures, and when and how to reopen society. 
One of the major challenges encountered in the field of epidemi-
ology is that the data and models are uncomparable, frequently 
incomplete, provisional, and subject to correction under chang-
ing conditions, making their use and reuse for timely epide-
miological analysis challenging. The principal guidelines for 
researchers are to ensure that the data models must be inclu-
sive of not only clinical data, disease milestones, indicators and 
reporting data, but also contact tracing and personal risk fac-
tors. Our recommendations for the policymakers are to incen-
tivise the publication of situational data, analytical models, 
scientific findings, and reports used in decision making.
Social sciences guidelines
The social sciences recommendations seek to ensure that social 
science data is widely (re)usable to answer fundamental ques-
tions about social aspects of the pandemic and that the data are 
accessible for work ongoing in other domains. The subgroup 
recommendations include: encouraging data management that 
follows best practices and improves data sharing; use of trust-
worthy repositories to share data; retention of information (e.g., 
geographic information) to allow data linkage within and across 
domains while maintaining confidentiality; access to measures 
that are useful when making statistical adjustments for selection 
bias, thereby improving the representativeness of findings from 
limited samples; and balancing the desire to share data widely 
with ensuring that human subjects protections are met and 
confidential data are kept secure.
Community participation guidelines
Community participation guidelines were created with the aim 
of bridging stakeholder involvement; ensuring that inputs from 
researchers, citizen scientists, developers and device makers 
are streamlined, with perspectives from patients, policymakers 
and the public at large also considered. Linking communities 
and supporting communication will help coordination and avoid 
duplication of efforts since many communities are driving simi-
lar or complementary efforts in response to the current public 
health emergency. These recommendations aim to support the 
varied work of communities in sharing data to improve research 
outputs and public knowledge.
Guidelines for data sharing respecting indigenous data 
sovereignty
Indigenous Peoples and nations globally need to be actively 
engaged in governance processes that include Indigenous-related 
COVID-19 data, data lifecycles, and data ecosystems. This 
is a necessary part of respecting the inherent rights of Indig-
enous nations to have sovereignty and governance over Indig-
enous data. The Indigenous COVID-19 data guidelines set out the 
minimum requirements for Indigenous-designed data approaches 
for funders, governments, researchers, and data stewards regarding 
governance, collection, ownership, application, sharing, and 
dissemination of Indigenous data, specifically in relation to 
COVID-19. These guidelines reflect and support Indigenous Data 
Sovereignty (see www.GIDA-global.org), underpinned by the 
United Nations Declaration on the Rights of Indigenous Peoples 
(UNDRIP) and framed around the CARE (for Collective Ben-
efit, Authority to Control, Responsibility, Ethics) Principles for 
Indigenous Data Governance (RDA, 2018). These guidelines 
do not supersede or replace existing Indigenous governance 
protocols or agreements developed (or under development) by 
Indigenous Peoples or nations. Rather, they point to the need for 
Indigenous Peoples and nations to be engaged in governance on 
their own terms across COVID-19 data lifecycles and ecosystems, 
so they are aligned to ethical and cultural Indigenous data practices 
supported by collective consent. This demands proactive invest-
ment in Indigenous community-controlled data infrastructures 
to support community capacity and resilience, and improve the 
flow of information for effective public health response.
Software guidelines
Regardless of the research domain, software plays a fundamental 
role to realise reproducible science as it enables analyses and 
processing of data. The recommendations for research soft-
ware covers aspects of development, release and maintenance, 
derived from previous work (Akhmerov et al., 2019; Anzt et al.,  
2020; Clément-Fontaine et al., 2019; Jiménez et al., 2017; 
Lamprecht et al., 2019; Wilson et al., 2017). Our recommenda-
tions to researchers focus on key practices enabling (re)use of 
research software making it easier for other researchers to build 
upon and focus their efforts on new approaches. Openness, 
availability, documentation and examples are key elements here. 
Before software is re-used, it must be found; therefore, our rec-
ommendations focus on software citation, archives and deposit 
platforms for released versions and alignment with publishing 
best practices. Finally, neither software development nor its 
publication are possible without sufficient funding support. In 
this sense, we centred our recommendations on increasing the 
recognition of software, its role in reproducibility, and funding 
opportunities not only for development but also for maintenance 
and sustainability.
Legal and ethics guidelines
Data sharing must occur in compliance with relevant legal 
and ethical frameworks. The legal and ethics section describes 
sources of legal and ethical obligations applicable to researchers 
performing studies on COVID-19, including biomedical and 
social science research ethics guidance. The section makes 
recommendations to help ensure best practices are respected 
in using COVID-19 data across jurisdictions and institutions. 
Recommendations include a synthesis of foundational principles 
of data privacy in law and ethics, and a description of organisa-
tional data governance practices. The recommendations also help 
researchers identify the most appropriate actor at their institution 
to guide them in adhering to local legal and ethical requirements. 
Data governance is considered throughout the data lifecycle 
in the spirit of community engagement and benefit sharing. 
Best practices for data de-identification and anonymisation, as 
well as data and software IP licensing are described. A discussion 
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of the distinct consent standards applicable to clinical care, 
research ethics, and data privacy law is incorporated. 
Overarching recommendations/foundational elements
In addition to each group’s recommendations, the document 
starts with a series of overarching recommendations. These 
foundational elements draw directly from the findings of the 
subgroups, as well as from broader current discussions on 
research data sharing and Open Science, tailored to the critical 
need for timely, precise, and interoperable research data sharing 
under a pandemic.
The sharing of research data promotes research integrity, ena-
bles others to investigate results, and fosters the very purpose of 
research itself - to build upon existing knowledge towards new 
discoveries. The timely sharing of well-curated data (and software, 
algorithms, and other resources) enables reuse, often for purposes 
unanticipated by the research that first produced the data. For 
this reuse to be possible, data must be collected, documented, 
curated, preserved, and made available through trusted and 
recognised platforms. The FAIR principles (Wilkinson et al., 
2016) - promoting data to be Findable, Accessible, Interoper-
able and Reusable - provide a well-recognised framework for 
data sharing, and were noted frequently by contributors across the 
sections.
Disciplinary borders provide one challenge, but so do 
geographical and administrative boundaries. COVID-19 does not 
respect borders of any kind, so, similarly, neither can research. 
The need for cross-jurisdictional efforts to support sharing of 
data and other resources, through coordination, funding and legal 
agreements, is also key. Computational infrastructures need to be 
refreshed and invested in as a public good; investment in technology 
needs to be accompanied by support for human resources to main-
tain infrastructure, and training programmes in data stewardship 
need to be developed and offered broadly. Data and other out-
puts need to be prepared for sharing so that they are understand-
able, and this process should be started as early as possible in the 
research process with the creation of a data management plan 
(DMP), which details how data will be stewarded throughout 
the research lifecycle. This lifecycle is key to the remaining 
‘Foundational’ elements: data must be accompanied by docu-
mentation such as research methods, context, data manipulation; 
rich metadata in standard formats need to accompany out-
puts, data should be deposited in domain-suitable trustworthy 
data repositories for discovery, preservation and reuse, and 
the rapid publication of data should be encouraged supported, 
and mandated by funders and publishers.
Discussion
A key aim of the recommendations and guidelines has been 
to offer both system-wide and concrete guidance to facilitate 
data sharing across disciplines and geographical boundaries in 
a timely and accurate manner, thus helping accelerate the time 
to a cure, supporting informed decisions and improving the 
global response to the pandemic.
The involvement of specialists and practitioners coming from 
the many disciplines and fields impacted by the pandemic 
has ensured that the report is both expert-informed, as well as 
community reviewed. The incorporation of repeated open con-
sultations was also meant to facilitate a fast track path to wider 
adoption, considering that researchers, policymakers and 
other stakeholders have been involved as early as possible in 
the formulation, drafting, and consensus on the document. 
The priority is for these guidelines and recommendations to be 
widely adopted in order to accelerate solutions to the pandemic.
Instead of a silo-based approach, the document points out the 
commonalities in data management across different research 
areas and themes. Identifying commonalities implies that simi-
lar solutions can be identified and applied. This bridge from 
the STEM (Science, Technology, Engineering, and Maths) to 
social science aspects of the COVID-19 challenge demon-
strated how truly interdisciplinary work across fields can provide 
valuable insights and stimulate a creative process. The added 
value of such overarching cooperations is a key takeaway from 
this process that is also likely to enrich similar efforts.
The document was developed with a comparatively light level of 
moderation and emerged on a very rapid time-frame of 10 weeks, 
including the release of five drafts for open consultation. 
Writing coordination focused on ensuring the flow of infor-
mation, so the sub-groups met regularly as did the moderators 
and chairs. There was a weekly webinar open to the public, as 
well weekly Co-Chairs meetings, and weekly coordination 
sessions for Chairs and Moderators; in addition, each subgroup 
agreed their own meeting plans. Small teams were set up for 
visualisation of recommendations, and for managing references. 
The foundational elements and executive summary were drafted 
by the editorial team, undergoing successive editing phases, where 
participants from different groups could comment widely across 
the whole document. This light-weight structure was enabled 
through relatively simple tools, namely Google Docs, Zot-
ero and conference calls. The final publication is designed as a 
reference text, where readers are likely to selectively read 
parts of the document relevant to them, so a certain degree of 
repetition on key advice was retained to address this selective 
reading.
Going forward, the RDA COVID-19 initiative has shown that 
there is a global willingness among experts from a range of dis-
ciplines to engage with the grand challenges we face as well as 
to generously offer their time and experience to generate thor-
ough and well-rounded guidance that is attentive to philosophi-
cal and pragmatic differences. This experience made clear that 
to a great extent, the knowledge, expertise, and solutions for 
working together in the face of global emergencies is already in 
place, so we need to foster this through continued coordination, 
harmonisation, and decision making.
Conclusions
The report has highlighted the importance of data sharing in 
different domains with respect to COVID-19. It provides a range 
of detailed guidelines aimed at communities with different 
practices of data management. The guidelines directly target 
researchers to facilitate best practices and maximise efficiency 
while also addressing policy makers, funders, publishers and 
providers of data infrastructures with a framework for future 
emergencies. With over 600 members, the group reached a 
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substantial size with diverse knowledge, background and domain 
experience.
As reflected in the content of this paper, going forward, the RDA 
COVID-19 WG is not only focused on the wider communica-
tion and adoption of the recommendations and guidelines them-
selves but also on providing best practices for the process of 
developing similar reports and outputs in the context of a multi-
disciplinary, bottom-up and geographically diverse community, 
to be able to answer global rapid challenges like the COVID-19 
pandemic.
The RDA is engaging with stakeholders at various levels to 
build impact and encourage adoption of the guidelines. From a 
policy perspective, the WG was instigated rapidly in response 
to a request by the European Commission and the guidelines 
are an important resource for the Organisation for Economic 
Co-operation and Development (OECD), the Bill and Melinda 
Gates Foundation, and the Wellcome Trust. From a research 
perspective, the work is continuing through a number of 
discipline-specific research papers, domain-focused narra-
tives, and use-cases, for example, within the epidemiology and 
legal/ethical subgroups. Furthermore, the process of forming the 
collaboration, developing the guidelines and quantifying their 
impact, is being analysed as a piece of social science research in 
its own right. Other group members are pursuing extended efforts 
through the creation of new interest or working groups through 
the RDA that will meet for the first time at virtual plenary in 
November 2020. The RDA itself is committed to sharing and 
improving the approach as an example of good practice, offer-
ing its structure and overall processes support as a framework for 
similar efforts.
The experience of writing the guidelines shows that the creation 
of a document with contributions from a large, diverse group 
is possible in a relatively short amount of time. Subgroups can 
operate in tandem to save time; however, they require editors to 
move different sections towards completion, and to help create a 
consistent structure and approach throughout the final document. 
A framework to steer the subgroups towards a common goal, 
particularly in terms of the intended audience, is also crucial. 
This community-driven writing can serve as a template for future 
world-wide urgent challenges such as the next pandemic, a natural 
disaster or indeed the climate crisis. The urgency and unprec-
edented global and near simultaneous nature of the pandemic 
likely contributed to participant motivation, and the question 
remains of how similarly large scale, multidisciplinary challenges 
may be addressed when the urgency is not as palpable. Without 
such urgency, this might attract fewer contributors. Nevertheless, 
as described here, this still provides a good mechanism for 
creating key guidelines that reflects a large diverse community.
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